Research

The purpose of the Andrew Carnegie Fellows Program is to support high-caliber scholarship in the social sciences and humanities, making it possible for the recipients to devote time to research and writing that addresses pressing issues and cultural transitions affecting us at home and abroad.

There are four broad topic areas that include a wide range of suggested subtopics:
Global connections and global ruptures
Strengthening U.S. democracy and exploring new narratives
Environments, natural and human
Technological and cultural creativity—potential and perils

The goals of the Nancy Grace Roman Technology Fellowship (RTF) program in astrophysics are to provide early-career researchers the opportunity to develop the skills necessary to lead astrophysics flight instrument development projects, including suborbital investigations, in preparation to become Principal Investigators (PIs) of future NASA astrophysics missions; to develop innovative technologies for space astrophysics that have the potential to enable major scientific breakthroughs; and to foster new talents by putting early career instrument builders on a trajectory towards long-term positions. NASA is committed to supporting deserving early career researchers by selecting several Roman Technology Fellows every year. This program is not linked to the Nancy Grace Roman Space Telescope (formerly WFIRST).

This program consists of two components with two different submission procedures. The first component is the one-page application from an early career individual to be named a Roman Technology Fellow (RTF), see Section 2. The second component is the subsequent submission of a proposal for up to $500K in Fellowship Funds by a previously selected RTF once that individual obtains a permanent or permanent-track position, in order to start a laboratory or develop a research group at the Fellow’s institution (see Section 3). Please see Section 2.1 for the definition of an early career position, and Section 4.1 for the definition of a permanent or permanent track position.

The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.

Ovarian Cancer Research Alliance is requesting Letters of Intent for the Early Career Investigator Grant (formerly called the Liz Tilberis Early Career Award). The Early Career Investigator Grant (ECIG) is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent of these grants is to support a substantial time commitment to research and academic endeavors in ovarian cancer.

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Only one NIDCD ECR Award (R21) application may be submitted by a PD/PI per due date. PD/PIs who successfully obtained an NIDCD Small Grant award are ineligible for an NIDCD ECR Award (R21).

Applicants may not submit an NIDCD R01, R15 or R21 application for the same review cycle that the NIDCD ECR Award application is submitted. In such cases, the NIDCD ECR Award R21 application will be withdrawn.

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Only one NIDCD ECR Award (R21) application may be submitted by a PD/PI per due date. PD/PIs who successfully obtained an NIDCD Small Grant award are ineligible for an NIDCD ECR Award (R21).

Applicants may not submit an NIDCD R01, R15 or R21 application for the same review cycle that the NIDCD ECR Award application is submitted. In such cases, the NIDCD ECR Award R21 application will be withdrawn.

This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative research in genomics. This opportunity is open to research in all areas relevant to the mission of NHGRI, including genomic sciences, genomic medicine, genomic data science, and ethical, legal, and social implications of genomics.

The PD/PI must be an NIH defined Early Stage Investigator, and this eligibility must be included in the NIH Commons record prior to the review of the application.

In addition, the PD/PI must be an independent researcher with a faculty appointment that is tenure track or equivalent (generally at the level of Assistant Professor or Research Assistant Professor), and have dedicated, independent laboratory space or access to the research resources which will allow them to conduct the research proposed in the grant application as the lead PD/PI

Since its inception, the NBF has awarded over $10 million to early-career investigators through its Scientific Research Grants Program. Many NBF early-career grant recipients have become leaders in the field. NBF awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.

Areas of Interest
Immunology

Alloimmunization, immune modulation, and tolerance
Animal models for the study of graft-vs-host disease
Biology of autoimmune hemolytic anemia

Hematology

Autologous and allogeneic stem cell transplants
Detection of residual disease following stem cell transplants
Effects of growth factors in vitro and in vivo
Biochemistry of coagulation factors

Immunohematology

Blood group serology
Biochemistry of red cell antigens
Molecular genetics of the blood groups

Infectious Diseases

Studies on Lyme disease, West Nile Virus, SARS and babesiosis and other emerging diseases
Effect of allogeneic transfusion in HIV-infected and immunocompromised patients
Improved detection of transfusion - transmitted diseases

Cellular Therapies

Cell separation, cell culture or expansion studies for cell therapy applications
Development of novel cell therapies or assays to measure cell viability or function
Pilot studies in regenerative medicine
Studies on mechanisms or roles of cells in stem cell transplantation
Studies on cytokines or growth factors involved in stem cell differentiation

Patient Blood Management

Treatment of pre-admission anemia and bleeding tendencies; Intraoperative/postoperative blood recovery; Surgical hemostasis; Appropriate indications for transfusion; Changing physician behaviors; Blood utilization review.

Brain Research Foundation invites eligible US institutions to nominate one faculty member (Assistant or Associate Professor) to submit a Letter of Intent (LOI) for the BRF Seed Grant Program.

Brain Research Foundation’s Annual Seed Grant Program was initiated in 1981. The purpose of our program is to provide start-up monies for new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources.

The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. BRF Seed Grant awards are not intended to supplement existing grants.

Each total grant is limited to $80,000 (direct costs) for a two year grant period. The first grant payment of $40,000 will be made upon completion of the Seed Grant Acceptance Form (June 2024). The final payment of $40,000 will be made contingent upon receipt of a preliminary progress and financial report (June 2025). Funds must be utilized within the grant period.

Areas of Interest
1.) Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

2.) Assistant Professor – Junior faculty with a new research project that will generate pilot data that will lead to RO1 funding or a comparable outside grant will be first priority.

• Must provide abstract and specific aims for current grants and indicate if there is any overlap.